These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11972510

  • 1. Thalidomide treatment in myelofibrosis with myeloid metaplasia.
    Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A.
    Br J Haematol; 2002 May; 117(2):288-96. PubMed ID: 11972510
    [Abstract] [Full Text] [Related]

  • 2. Thalidomide in agnogenic and secondary myelofibrosis.
    Canepa L, Ballerini F, Varaldo R, Quintino S, Reni L, Clavio M, Miglino M, Pierri I, Gobbi M.
    Br J Haematol; 2001 Nov; 115(2):313-5. PubMed ID: 11703326
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.
    Barosi G, Grossi A, Comotti B, Musto P, Gamba G, Marchetti M.
    Br J Haematol; 2001 Jul; 114(1):78-83. PubMed ID: 11472348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia.
    Merup M, Kutti J, Birgergård G, Mauritzson N, Björkholm M, Markevärn B, Maim C, Westin J, Palmblad J, Swedish National Study Group on Chronic Myeloproliferative Disorders.
    Med Oncol; 2002 Jul; 19(2):79-86. PubMed ID: 12180484
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B, Ho CL, Hoyer JD, Mesa RA, Tefferi A.
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [Abstract] [Full Text] [Related]

  • 12. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
    Abgrall JF, Guibaud I, Bastie JN, Flesch M, Rossi JF, Lacotte-Thierry L, Boyer F, Casassus P, Slama B, Berthou C, Rodon P, Leporrier M, Villemagne B, Himberlin C, Ghomari K, Larosa F, Rollot F, Dugay J, Allard C, Maigre M, Isnard F, Zerbib R, Cauvin JM, Groupe Ouest-Est Leucémies et Maladies du Sang (GOELAMS).
    Haematologica; 2006 Aug; 91(8):1027-32. PubMed ID: 16885042
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.